Recently, mice with a mutation of myeloid-lineage leukemia gene (Mll2), a histone methyltransferase functioning during development, have been shown to develop hyperinsulinemia and have lowered hepatic Enpp1 expression compared with the wildtype controls, suggesting the regulation of its expression by histone modification (38). This evidence concerns the gene PRDM9 and hyperinsulinism.